Rigel Pharmaceuticals, Inc. (RIGL) Ownership
RIGL ownership summary
as of October 18, 2026- Institutions
- 92.2% of shares outstanding
- Insiders
- 3.35% of shares outstanding
- Shares outstanding
- 18.7M
- Float
- 14.8M shares available to trade
- Short interest
- 15.69% 2.9M shares short
- Days to cover
- 12.24 short interest down 10.5% vs prior month
- Institutions 92.19%
- Insiders 3.35%
- Other investors 4.46%
RIGL top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 10.38% | 1.9M | $89.2M | +170,911 (+9.7%) | June 30, 2026 |
| 2 | Soleus Capital Management, L.P. | 9.87% | 1.8M | $84.7M | +1.8M (+18,335.0%) | June 30, 2026 |
| 3 | Armistice Capital, LLC | 8.95% | 1.7M | $76.9M | +392,000 (+30.6%) | June 30, 2026 |
| 4 | State Street Corp | 5.57% | 1.0M | $47.8M | −80,244 (−7.2%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 4.20% | 785K | $36.1M | +20,914 (+2.7%) | June 30, 2026 |
| 6 | American Century Companies Inc | 3.97% | 742K | $34.1M | +197,287 (+36.2%) | June 30, 2026 |
| 7 | LSV Asset Management | 3.86% | 722K | $33.2M | +120,159 (+20.0%) | June 30, 2026 |
| 8 | Acadian Asset Management LLC | 3.17% | 592K | $27.2M | −74,740 (−11.2%) | June 30, 2026 |
| 9 | D. E. Shaw & Co LP | 2.90% | 543K | $24.9M | +96,861 (+21.7%) | June 30, 2026 |
| 10 | Geode Capital Management, LLC | 2.59% | 483K | $22.2M | +42,549 (+9.7%) | June 30, 2026 |
| 11 | Marshall Wace Asset Management Ltd | 1.97% | 367K | $16.9M | −230,985 (−38.6%) | June 30, 2026 |
| 12 | CM Management, LLC | 1.34% | 250K | $11.5M | +15,000 (+6.4%) | June 30, 2026 |
| 13 | Vanguard Portfolio Management, LLC | 1.25% | 234K | $10.7M | +86,193 (+58.4%) | June 30, 2026 |
| 14 | Dimensional Fund Advisors, Inc. | 1.22% | 228K | $10.5M | −151,590 (−39.9%) | June 30, 2026 |
| 15 | The Goldman Sachs Group Inc | 1.21% | 227K | $10.4M | −212,321 (−48.4%) | June 30, 2026 |
| 16 | Two Sigma Investments LLC | 1.11% | 208K | $9.5M | −198,229 (−48.8%) | June 30, 2026 |
| 17 | Delaware Management Holdings Inc | 1.04% | 195K | $9.0M | +195,000 (0.0%) | June 30, 2026 |
| 18 | Morgan Stanley - Brokerage Accounts | 1.00% | 186K | $8.6M | +87,181 (+88.2%) | June 30, 2026 |
| 19 | Charles Schwab Investment Management Inc | 0.83% | 155K | $7.1M | −22,223 (−12.6%) | June 30, 2026 |
| 20 | Northern Trust Corp | 0.78% | 146K | $6.7M | +11,811 (+8.8%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 3.3M shares and 7 cut 970K.
RIGL top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Avantis US Small Cap Value ETF | 4.67% | 872K | $40.1M | +2,928 (+0.3%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 2.98% | 556K | $25.6M | — | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 2.56% | 478K | $22.0M | −5,504 (−1.1%) | September 30, 2026 |
| 4 | State Street® SPDR® S&P® Biotech ETF | 2.55% | 477K | $21.9M | −9,100 (−1.9%) | September 30, 2026 |
| 5 | Fidelity Small Cap Index | 1.08% | 201K | $9.3M | +1,825 (+0.9%) | July 31, 2026 |
| 6 | iShares Russell 2000 Value ETF | 0.91% | 170K | $7.8M | +258 (+0.2%) | September 30, 2026 |
| 7 | Nomura Healthcare Fund Class I | 0.86% | 160K | $7.4M | — | August 31, 2026 |
| 8 | iShares Biotechnology ETF | 0.76% | 142K | $6.5M | −1,072 (−0.8%) | September 30, 2026 |
| 9 | Hillsdale US Small Cap Eq Fund Srs A U$ | 0.70% | 131K | $6.0M | — | December 31, 2025 |
| 10 | BlackRock Advantage Small Cap Core Instl | 0.60% | 112K | $5.1M | +2,508 (+2.3%) | August 31, 2026 |
| 11 | Vanguard Russell 2000 ETF | 0.57% | 107K | $4.9M | +1,227 (+1.2%) | September 30, 2026 |
| 12 | Schwab US Small-Cap ETF™ | 0.53% | 100K | $4.6M | +63 (+0.1%) | September 30, 2026 |
| 13 | Fidelity Extended Market Index | 0.48% | 90K | $4.2M | −1,756 (−1.9%) | August 31, 2026 |
| 14 | EA Bridgeway Omni Small-Cap Value ETF | 0.46% | 86K | $3.9M | — | September 30, 2026 |
| 15 | First Trust Dow Jones Sel MicroCap ETF | 0.43% | 81K | $3.7M | — | September 30, 2026 |
| 16 | Indosuez Funds America Small&Mid Caps G | 0.42% | 78K | $3.6M | +49,364 (+171.4%) | August 31, 2026 |
| 17 | LSV Small Cap Value Institutional | 0.39% | 74K | $3.4M | — | September 30, 2026 |
| 18 | Avantis® U.S. Small Cap Value Instl | 0.36% | 66K | $3.0M | +6,971 (+11.7%) | September 30, 2026 |
| 19 | iShares Micro-Cap ETF | 0.31% | 58K | $2.7M | −400 (−0.7%) | September 30, 2026 |
| 20 | Principal US Small Cap ETF | 0.30% | 55K | $2.5M | +27 (+0.0%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
RIGL insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-20 | Walter H Moos | Sell | $36.36 | 4,000 | $145,440 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
RIGL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns RIGL
Institutional investors own 92.2% of Rigel Pharmaceuticals's shares and insiders 3.35%. The largest holder is BlackRock Inc with 10.38% of the shares (1.9M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 15.69% of the float, or 12.24 days of average trading volume. The share count rose 114.6% since 2014.
Related: RIGL analyst forecast, RIGL key metrics. See the RIGL stock overview for the latest quote and news.
RIGL ownership FAQ
Who owns the most Rigel Pharmaceuticals stock?
The largest shareholders of Rigel Pharmaceuticals are BlackRock Inc (10.38%), Soleus Capital Management, L.P. (9.87%), Armistice Capital, LLC (8.95%), State Street Corp (5.57%), Vanguard Capital Management, LLC (4.20%).
What percentage of Rigel Pharmaceuticals is owned by institutions?
Institutions hold 92.2% of Rigel Pharmaceuticals's shares outstanding; insiders hold 3.35%.
Which funds own Rigel Pharmaceuticals?
The largest fund holders of Rigel Pharmaceuticals are Avantis US Small Cap Value ETF (4.67%), Vanguard MStar Total Stk Mkt Idx Invest (2.98%), iShares Russell 2000 ETF (2.56%), State Street® SPDR® S&P® Biotech ETF (2.55%), Fidelity Small Cap Index (1.08%).
What is Rigel Pharmaceuticals's short interest?
2.9M shares of Rigel Pharmaceuticals were sold short, 15.69% of the float; at the average daily volume it would take 12.24 days to cover.
Are insiders buying or selling Rigel Pharmaceuticals?
Of the latest 1 reported insider transactions in Rigel Pharmaceuticals (since February 20, 2026), 0 were purchases and 1 were sales.
How many shares of Rigel Pharmaceuticals are outstanding?
Rigel Pharmaceuticals has 18.7M shares outstanding, of which 14.8M are in the public float.